3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
10
Weight Loss
5
Obesity
5
Overweight
3
Menstruation Disturbances
2
Intermittent Fasting
2
Tumor Surgery
1
Sarcopenia
1
Postoperative Complications
1
Obesity, Abdominal
1
Muscle Weakness
1
Moderately Overweight Individuals
1
Metabolic Syndrome
1
Metabolic Diseases
1
Insulin Resistance
1
Infertility
1
Glucocorticoid Receptor Deficiency
1
Fasting
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Breast Cancer Female
1
Interventions
Inositol
3
Clomiphene
3
cetrorelix
2
Uterine Myomectomy
2
Triptorelin Pamoate
2
Psychiatric Rehabilitation
2
Medroxyprogesterone Acetate
2
Letrozole
2
Fertilization in Vitro
2
Dydrogesterone
2
Counseling
2
follitropin alfa
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Therapeutics
1
Sugars
1
Raloxifene Hydrochloride
1
Progestins
1
Metformin
1
Lactalbumin
1
Iodine-131
1
Intravital Microscopy
1
Folic Acid
1
Flutamide
1
Ethinyl Estradiol
1
Diet, Vegetarian
1
Diet, Vegan
1
Diet Therapy
1
Diet
1
Caloric Restriction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Infertility
×
Caloric Restriction
×
Clear all
NCT01716429
2019-04-18
HER Health
University of South Carolina
Phase NA
Withdrawn